ArticleJournal of animal science2025
Effect of oral glutamine supplementation on growth and glutamine and glucose metabolism in suckling piglets.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glutamine and Its Precursors Supplementation Improve Growth Performance and Immunity and Regulate Gastrointestinal Microbiota of Suckling Lambs.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The increase in litter size has led to a higher proportion of low birthweight (LBW) piglets, which are disadvantaged in terms of later growth and organ maturation. Supplementing with glutamine (Gln) has been proposed to improve this situation. We investigated the metabolism of Gln and glucose (Glc) in LBW and normal (NBW) birthweight (BiW) suckling piglets supplemented with Gln or water (W). Forty-six neonatal male German Landrace piglets with a BiW of 1.04 ± 0.02 kg for LBW piglets and 1.55 ± 0.02 kg for NBW piglets were assigned to one of four treatments in a 2 × 2 factorial design (LBW/NBW; Gln/W). Half of the groups received either 1 g/kg bodyweight (BW)/d of Gln (LBW-Gln, NBW-Gln; n = 12) dissolved in water, or water (W) as a control (LBW-W, NBW-W; n = 11), until age 15 d. At 12 d, piglets were implanted a jugular vein catheter and then underwent oral tests: on 14 d with 13C5-Gln/Gln, on 15 d with lactulose/mannitol (Lac/Man) and on 16 d with 13C6-Glc/Glc and xylose (Xyl). After a baseline blood sample, blood samples were collected over 5 h. Enrichments of 13C tracers in plasma and 13CO2 in red blood cells (RBC) were measured, along with plasma concentrations of Lac, Man, Xyl, Glc, lactate, urea, and amino acids. We calculated plasma Gln and Glc rate of appearance (Ra), 13C recovery (13C REC) in RBC CO2 from 13C5-Gln and 13C6-Glc as a proxy of whole-body oxidation and 13C6-Gln conversion to 13C3-Glc to obtain a measure of gluconeogenesis. The BW, average daily gain (ADG), abdominal circumference (ABC), crown-rump length (CRL), body mass index (BMI), and ponderal index were measured. The BW of LBW piglets supplemented with Gln was lower than of those supplemented with W at 12, 13, and 15 d (P < 0.05). The BW, ADG, ABC, CRL, and BMI remained lower in LBW than in NBW piglets (P < 0.01). Plasma urea was higher in the Gln groups (P < 0.05). The Xyl and Man absorption tests indicated a greater intestinal absorptive capacity/area in LBW piglets (P < 0.05). The 13C REC values of Gln and Glc were higher in LBW than in NBW piglets (P < 0.01), whereas 13C REC of Gln was higher than that of Glc independently of BiW and supplementation (P = 0.005). Plasma 13C6-Glc Ra was higher than that of 13C5-Gln Ra in all groups (P < 0.01). The 13C5-Gln to 13C3-Glc conversion did not differ among groups (P > 0.1). In conclusion, LBW and NBW piglets differ in Gln and Glc metabolism, but Gln supplementation did not show a consistent effect on the measured parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.